Immunology continues to be one of the most active areas for drug research as the field aims to bring patients new ways to eliminate the antibodies driving autoimmune disease, but in a manner that does ...
- Series A financing co-led by Bain Capital Life Sciences, BVF Partners and Third Rock Ventures CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merida Biosciences, a biotechnology company pioneering a new class of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback